Unmodified or minimally modified peptide chains, often requiring parenteral delivery due to gut lability.

5 assets

Peptide cyclized by disulfide or head-to-tail linkages to improve proteolytic stability and receptor selectivity.

1 asset

Hydrocarbon or lactam stapling to lock helical or bioactive conformations, improving cell permeability and target engagement.

1 asset

Non-peptide small molecules or peptide formulations designed for oral bioavailability, including SNAC-enabled peptides.

5 assets